BACKGROUND: Here, we ask whether platelet GPIb and GPIIb/IIIa receptors modulate platelet sequestration and activation during GalTKO.hCD46 pig lung xenograft perfusion. METHODS: GalTKO.hCD46 transgenic pig lungs were perfused with heparinized fresh human blood. Results from perfusions in which αGPIb Fab (6B4, 10 mg/l blood, n = 6), αGPIIb/IIIa Fab (ReoPro, 3.5 mg/l blood, n = 6), or both drugs (n = 4) were administered to the perfusate were compared to two additional groups in which the donor pig received 1-desamino-8-d-arginine vasopressin (DDAVP), 3 μg/kg (to pre-deplete von Willebrand Factor (pVWF), the main GPIb ligand), with or without αGPIb (n = 6 each). RESULTS: Platelet sequestration was significantly delayed in αGPIb, αGPIb+DDAVP, and αGPIb+αGPIIb/IIIa groups. Median lung "survival" was significantly longer (>240 vs. 162 min reference, p = 0.016), and platelet activation (as CD62P and βTG) were significantly inhibited, when pigs were pre-treated with DDAVP, with or without αGPIb Fab treatment. Pulmonary vascular resistance rise was not significantly attenuated in any group, and was associated with residual thromboxane and histamine elaboration. CONCLUSIONS: The GPIb-VWF and GPIIb/IIIa axes play important roles in platelet sequestration and coagulation cascade activation during GalTKO.hCD46 lung xenograft injury. GPIb blockade significantly reduces platelet activation and delays platelet sequestration in this xenolung rejection model, an effect amplified by adding αGPIIb/IIIa blockade or depletion of VWF from pig lung.
BACKGROUND: Here, we ask whether platelet GPIb and GPIIb/IIIa receptors modulate platelet sequestration and activation during GalTKO.hCD46 pig lung xenograft perfusion. METHODS: GalTKO.hCD46 transgenic pig lungs were perfused with heparinized fresh human blood. Results from perfusions in which αGPIb Fab (6B4, 10 mg/l blood, n = 6), αGPIIb/IIIa Fab (ReoPro, 3.5 mg/l blood, n = 6), or both drugs (n = 4) were administered to the perfusate were compared to two additional groups in which the donor pig received 1-desamino-8-d-arginine vasopressin (DDAVP), 3 μg/kg (to pre-deplete von Willebrand Factor (pVWF), the main GPIb ligand), with or without αGPIb (n = 6 each). RESULTS: Platelet sequestration was significantly delayed in αGPIb, αGPIb+DDAVP, and αGPIb+αGPIIb/IIIa groups. Median lung "survival" was significantly longer (>240 vs. 162 min reference, p = 0.016), and platelet activation (as CD62P and βTG) were significantly inhibited, when pigs were pre-treated with DDAVP, with or without αGPIb Fab treatment. Pulmonary vascular resistance rise was not significantly attenuated in any group, and was associated with residual thromboxane and histamine elaboration. CONCLUSIONS: The GPIb-VWF and GPIIb/IIIa axes play important roles in platelet sequestration and coagulation cascade activation during GalTKO.hCD46 lung xenograft injury. GPIb blockade significantly reduces platelet activation and delays platelet sequestration in this xenolung rejection model, an effect amplified by adding αGPIIb/IIIa blockade or depletion of VWF from pig lung.
Authors: Heidi Yeh; Zurab Machaidze; Isaac Wamala; James W Fraser; Nalu Navarro-Alvarez; Karen Kim; Christian Schuetz; Shuai Shi; Alexander Zhu; Martin Hertl; Nahel Elias; Evan A Farkash; Parsia A Vagefi; Manish Varma; Rex Neal Smith; Simon C Robson; Elizabeth M Van Cott; David H Sachs; James F Markmann Journal: Xenotransplantation Date: 2014-08-01 Impact factor: 3.907
Authors: Jan Schulte am Esch; Simon C Robson; Wolfram T Knoefel; Claus F Eisenberger; Matthias Peiper; Xavier Rogiers Journal: Br J Haematol Date: 2005-01 Impact factor: 6.998
Authors: E Cantu; K R Balsara; B Li; C Lau; S Gibson; A Wyse; K Baig; J Gaca; G V Gonzalez-Stawinski; T Nichols; W Parker; R D Davis Journal: Am J Transplant Date: 2006-11-15 Impact factor: 8.086
Authors: Donald G Harris; Kevin J Quinn; Beth M French; Evan Schwartz; Elizabeth Kang; Siamak Dahi; Carol J Phelps; David L Ayares; Lars Burdorf; Agnes M Azimzadeh; Richard N Pierson Journal: Xenotransplantation Date: 2014-12-02 Impact factor: 3.907
Authors: Christine L Lau; Edward Cantu; Gonzalo V Gonzalez-Stawinski; Zoie E Holzknecht; Timothy C Nichols; Katherine E Posther; Cory A Rayborn; Jeffrey L Platt; William Parker; R Duane Davis Journal: Am J Transplant Date: 2003-09 Impact factor: 8.086
Authors: Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares Journal: Science Date: 2002-12-19 Impact factor: 47.728
Authors: Arielle Cimeno; Wessam Hassanein; Beth M French; Jessica M Powell; Lars Burdorf; Olga Goloubeva; Xiangfei Cheng; Dawn M Parsell; Jagdeece Ramsoondar; Kasinath Kuravi; Todd Vaught; Mehmet C Uluer; Emily Redding; Natalie O'Neill; Christopher Laird; Alena Hershfeld; Ivan Tatarov; Kathryn Thomas; David Ayares; Agnes M Azimzadeh; Richard N Pierson; Rolf N Barth; John C LaMattina Journal: Xenotransplantation Date: 2017-09-22 Impact factor: 3.907
Authors: Zahra A Habibabady; Selin Sendil; Felix Ellett; Franziska Pollok; Gabriela F Elias; Beth M French; Wenji Sun; Gheorghe Braileanu; Lars Burdorf; Daniel Irimia; Richard N Pierson; Agnes M Azimzadeh Journal: Xenotransplantation Date: 2022-02-02 Impact factor: 3.907
Authors: Parth M Patel; Margaret R Connolly; Taylor M Coe; Anthony Calhoun; Franziska Pollok; James F Markmann; Lars Burdorf; Agnes Azimzadeh; Joren C Madsen; Richard N Pierson Journal: Front Immunol Date: 2021-09-09 Impact factor: 7.561